BEAM compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

BEAMBeam Therapeutics Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

BEAMBeam Therapeutics Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

BEAM

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±13.1%▲+1.78%×0.14

Q2 FY26±13.3%▲+9.42%×0.71

May 7 '26±9.2%▼−2.69%×0.29

Q1 FY26±19.4%▲+13.98%×0.72

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%▲+3.73%×1.00

Q2 FY26±4.1%▲+4.57%×1.12

= impliedBEAM realized, solidAMGN realized, hatchedOne scale, both sides: full bar = 20%× = |realized| ÷ impliedSource: market data

Q1 FY26

±3.9%

▼−4.75%

×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

BEAMBeam Therapeutics Inc.

26.42▲+2.13%· post 26.72

Mkt cap$2.7BRevenue$307,000Q3 FY26Revenue$140MFY25

AMGNAmgen Inc

460.55▲+0.06%· post 460.42

ClosedNov 6 '26

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

ClosedNov 6 '26

BEAMBeam Therapeutics Inc.

AMGNAmgen Inc

26.42▲+2.13%post 26.72

Price

460.55▲+0.06%post 460.42

$2.7B

Mkt cap

$249.0B

Q3 FY26$307,000

Revenue

$10.4BQ3 FY26

FY25$140M

Revenue

$36.8BFY25

BEAM26.42▲+2.13%vsAMGN460.55▲+0.06%ClosedNov 6 '26